Dr. Reddy’s Wins Rulings Over Three Patents For Suboxone Drug

The District Court of Delaware has ruled in favour of Dr. Reddy’s Laboratories Ltd. against Reckitt Benckiser for the blockbuster drug Suboxone.

Even with the assumption that three generics version of the drug hit the market - manufactured by Dr. Reddy’s, Actavis and Par Pharmaceutical - Suboxone could add Rs 30 to its EPS, the broking firm said.

However, this upside may take some time as the innovator may likely appeal the decision in a higher court. Dr. Reddy’s, on the other hand, still needs to get an approval from the U.S. Food and Drug Administration.